Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



AMGEN INC. Hits Price Target Forecast with 20.66% Profit: A Win for QuantWave

February 01, 2024
AMGEN INC. has successfully reached the price target forecast set by QuantWave, resulting in a profit of 20.66%. The forecast signal was initiated on November 7, 2023, at a price of 254.68 $. The predicted direction was long, and on February 1, 2024, the stock reached the target price of 307.29 $. This achievement showcases the accuracy and effectiveness of QuantWave's analytics in guiding investors towards profitable trades.

The market analysis of AMGEN INC. reveals several potential factors that contributed to this stock movement. The company has been showing strong financial performance, with positive earnings reports and promising developments in its pipeline of biopharmaceutical products. Additionally, favorable industry trends and market conditions have further supported the stock's upward trajectory.

This successful forecast for AMGEN INC. holds significance not only for the investors who benefited from the profitable trade but also for QuantWave as a leading automated forecasting platform. By consistently delivering accurate predictions and helping users achieve profitable outcomes, QuantWave has established itself as a reliable source for stock market insights.

QuantWave offers a wide range of stock predictions, providing opportunities for potential profits to investors. For those looking to enhance their investment strategies, exploring the educational resources of QuantSchool is highly recommended. QuantSchool offers a comprehensive professional investment framework that reveals key principles for generating consistent income using the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for AMGN

Related data

AMGNJuly 30, 2025Amgen Inc. NASDAQ:AMGN Shares Unloaded by Rep. Jefferson Shreve  ~1 min.

Recently, Representative Jefferson Shreve unloaded a significant number of Amgen Inc. (NASDAQ:AMGN) shares....


AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....


AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....


AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....


AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....


AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....


AMGNMarch 10, 2025AMGEN INC. Hits Price Target Forecast with 20.7% Profit: A Success Story for QuantWave  ~1 min.

AMGEN INC. has recently reached the price target forecast set by QuantWave, resulting in a significant profit of 20.7% for investors who followed the predictive signal....


AMGNMarch 7, 2025AMGEN INC. Hits Price Target Forecast with 19.78% Profit, as Predicted by QuantWave  ~2 min.

AMGEN INC. (AMGN) recently achieved the price target forecast set by QuantWave, resulting in a profit of 19.78% for investors who followed the prediction....


AMGNFebruary 27, 2025Amgen Inc. AMGN: A Promising Investment Opportunity in the Pharmaceutical Industry  ~2 min.

Amgen Inc. (AMGN), a leading biotechnology company, is regarded as one of the best investment options in the pharmaceutical sector, according to analysts at Yahoo Finance....


AMGNFebruary 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts  ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....


REGNAugust 19, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 14.57% Profit Margin  ~1 min.

On July 2nd, 2024, QuantWave issued a forecast signal for REGENERON PHARMACEUTICALS, INC., predicting a long position when the stock was trading at 1041.78 $....


AMGNNovember 19, 2024Amgen Inc. AMGN: Revolutionizing the Biopharmaceutical Industry  ~2 min.

Amgen Inc., a leading biopharmaceutical company, is making waves in the industry with its innovative research and development....


AMGNNovember 8, 2022AMGEN INC. Hits Price Target Forecast with 19.38% Profit, Confirms QuantWave's Accuracy  ~1 min.

AMGEN INC. has successfully reached the price target forecast set by QuantWave's automated forecasting platform on November 8, 2022....


AMGNJanuary 8, 2024AMGEN INC. Hits Price Target Forecast with 23.35% Profit on QuantWave Platform  ~2 min.

On September 5, 2023, QuantWave, the automated forecasting platform, issued a long signal for AMGEN INC. stock when it was trading at $240.55....


AMGNAugust 8, 2023AMGEN INC. Hits QuantWave's Price Target Forecast with 15.91% Profit  ~1 min.

AMGEN INC. has successfully reached QuantWave's price target forecast, resulting in a profit of 15.91%. The forecast signal date was July 3, 2023, with the stock price at 209.67 $....